美国辉瑞欲收购英国阿斯利康
关键字:美国辉瑞
美国药企辉瑞(Pfizer)想要收购英国制药商阿斯利康(AstraZeneca),对后者的估值可能超过1,000亿美元。如果二者合并,将形成全球制药行业中的新巨头。辉瑞周一证实,曾在1月向阿斯利康提出收购意向,并于4月26日再次与其接触,寻求就收购事宜展开讨论。阿斯利康这两次均拒绝展开洽谈,股价早盘大涨15%。
推荐阅读
本文来源: 大田环球贵金属
最新内容
Risk Warning
Trading bullion and financial instruments carries significant risks and may not be suitable for all investors, requiring careful consideration of investment objectives, experience, and risk tolerance. Key risks include market volatility, leverage risks that can amplify gains or losses, liquidity issues that may prevent executing trades at desired prices, and technical failures in online trading systems. Prices fluctuate unpredictably, and past performance does not guarantee future results. CIDT Global Bullion Limited provides general market commentary but does not offer investment advice and is not liable for any losses incurred from reliance on its information, which may change without notice.
Jurisdiction Disclaimer
CIDT Global Bullion Limited's services are subject to local regulations and may not be available in all jurisdictions. Users are responsible for ensuring compliance with their local laws. Services are not provided in regions where they are prohibited by law, under international sanctions, or require licensing that the company does not hold. By using the platform, users confirm they are not in a restricted jurisdiction and accept full responsibility for legal compliance. The company reserves the right to decline or terminate services in restricted areas without prior notice.